PTEN Loss as Determined by Clinical-grade Immunohistochemistry Assay Is Associated with Worse Recurrence-free Survival in Prostate Cancer Article

sustainable development goals

publication date

  • June 1, 2016

webpage

published in

keywords

  • Biomarker
  • ERG
  • Immunohistochemistry
  • PTEN
  • Prostatic carcinoma
  • Radical prostatectomy

start page

  • 180

end page

  • 188

volume

  • 2

issue

  • 2